Aberrant CD7, CD56 and CD79a antigen expression in acute myeloid leukemias

被引：0
|
作者：
Cruse, JM [1 ]
Lewis, RE [1 ]
Pierce, SL [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A507 / A507
页数：1
相关论文
共 50 条
  • [21] Aberrant Expression of CD56 in Metastatic Malignant Melanoma
    White, Karah D.
    Kerkvliet, Amy M.
    Jassim, Ali D.
    CUTIS, 2023, 112 (05): : E13 - E15
  • [22] Aberrant CD56 expression in primary cutaneous plasmacytoma
    Galan, A.
    Milstone, E.
    Subtil, A.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (01) : 154 - 154
  • [23] Clinical significance of CD56 expression in patients with acute myeloid leukemia
    Lee, JJ
    Chung, IJ
    Yang, DH
    Cho, SH
    Cho, D
    Ryang, DW
    Kim, HJ
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1897 - 1899
  • [24] Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia
    Sasca, Daniel
    Schueler, Andrea
    Szybinski, Jakub
    Kriege, Oliver
    Kunz, Kerstin
    Fehr, Eva Marie
    Haehnel, Patricia
    Gebhardt, Wolf Henning
    Reid, Gerge
    Theobald, Matthias
    Bullinger, Lars
    Kindler, Thomas
    BLOOD, 2015, 126 (23)
  • [25] A near tetraploid clone in acute myeloid leukemia with CD56 expression
    Gundimeda, Sandhya Devi
    Ahmed, Faiq
    Mundada, Manasi Chetan
    Rajappa, Senthil Jagannathan
    Murthy, Sudha S.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (01) : 187 - 190
  • [26] Targeting aberrant NCAM (neural cell adhesion molecule; CD56) expression in acute myeloid leukemia
    Sasca, D.
    Schueler, A.
    Kriege, O.
    Kunz, K.
    Szybinski, J.
    Fehr, E-M
    Haehnel, P. S.
    Gebhardt, W. H.
    Reid, G.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    Oncology Research and Treatment, 2015, 38 : 8 - 8
  • [27] TARGETING ABERRANT NCAM (NEURAL CELL ADHESION MOLECULE; CD56) EXPRESSION IN ACUTE MYELOID LEUKEMIA
    Sasca, D.
    Kriege, O.
    Kunz, K.
    Schueler, A.
    Szybinski, J.
    Fehr, E. M.
    Haehnel, P.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    HAEMATOLOGICA, 2015, 100 : 34 - 35
  • [28] CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity
    Kozlov, I
    Beason, K
    Yu, C
    Hughson, M
    CANCER GENETICS AND CYTOGENETICS, 2005, 163 (01) : 62 - 67
  • [29] Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation
    Rausei-Mills, Veronica
    Chang, Karen L.
    Gaal, Karl K.
    Weiss, Lawrence M.
    Huang, Qin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (04) : 624 - 629
  • [30] Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3-ITD mutation
    Rausie-Mills, V.
    Chang, K. L.
    Gaal, K. K.
    Weiss, L. M.
    Huang, Q.
    LABORATORY INVESTIGATION, 2007, 87 : 257A - 257A
12345